Nanochon

Nanochon is a privately held medical device company founded in 2016, focused on developing innovative 3D-printed implants for cartilage repair in orthopedic applications. The company targets "pre-replacement" patients with focal cartilage lesions, particularly in the knee, who suffer from pain and reduced quality of life but are not yet candidates for joint replacement.

The flagship product, Chondrograft™, is a 3D-printed implant designed for focal cartilage defects. It integrates with the body's natural healing processes, promoting tissue regeneration and recovery. Nanochon utilizes a proprietary nylon-based composite material that mimics the structure and mechanical properties of natural cartilage, providing immediate support and acting as a scaffold for new tissue growth. The company is advancing toward human clinical studies and regulatory approval, emphasizing minimally invasive and scalable solutions. Nanochon has established partnerships, including a contract manufacturing deal with BICO's SCIENION for the production of its regenerative joint implants.